Akston Biosciences Corporation (AXTN)

Akston Biosciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2024	Dec 31, 2023
Market Capitalization	68	-	-
Enterprise Value	76	-	-
Debt / Equity Ratio	-0.84	-2.40	-0.58
Debt / EBITDA Ratio	2.19	1.40	-0.83
Debt / FCF Ratio	-0.68	-0.81	-1.30
Quick Ratio	0.70	0.63	0.07
Interest Coverage	1.86	2.78	-
Return on Equity (ROE)	-10.73%	-82.30%	83.49%
Return on Assets (ROA)	-	36.72%	-72.11%
Return on Capital (ROIC)	814.46%	-223.26%	191.13%
Return on Capital Employed (ROCE)	-77.98%	89.98%	986.05%

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).